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Available online 28 June 2016Background: Post-operative atrial ﬁbrillation (POAF) is a major health economic burden. However, the precise
mechanisms in POAF remain unclear. In other forms of AF, sites of high dominant frequency (DF) in sinus rhythm
(SR) may harbour ‘AF nests’. We studied AF inducibility in relation to substrate changes using epicardial electro-
grams and cardiomyocyte calcium handling in the atria of AF naïve patients.
Method: Bipolar electrogramswere recorded from the lateral right atrial (RA)wall in 34 patients undergoing cor-
onary surgery using a high-density array in sinus rhythm (NSR). RA burst pacing at 200/500/1000 ms cycle
lengths (CL) was performed, recording episodes of AF N 30 s. Co-localised RA tissue was snap frozen for RNA
and protein extraction.
Results: Electrograms prolonged during AF (76.64 ± 29.35 ms) vs. NSR/pacing (p b 0.001). Compared to NSR,
electrogram amplitude was reduced during AF and during pacing at 200 ms CL (p b 0.001). Electrogram DF
was signiﬁcantly lower in AF (75.87 ± 23.63 Hz) vs. NSR (89.33 ± 25.99 Hz) (p b 0.05), and NSR DF higher in
AF inducible patients at the site of AF initiation (p b 0.05). Structurally, POAF atrial myocardium demonstrated
reduced sarcolipin gene (p = 0.0080) and protein (p = 0.0242) expression vs. NSR. Phospholamban gene and
protein expression was unchanged. SERCA2a protein expression remained unchanged, but MYH6 (p =
0.0297) and SERCA2A (p = 0.0343) gene expression was reduced in POAF.
Conclusions:Human atrial electrograms prolong and reduce in amplitude in induced peri-operative AF vs. NSR or
pacing. In those sustaining AF, high DF sites in NSR may indicate ‘AF nests’. This electrical remodelling is accom-
panied by structural remodelling with altered expression of cardiomyocyte calcium handling detectable before
POAF. These novel upstream substrate changes offer a novel mechanism and manifestation of human POAF.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
Atrial ﬁbrillation
Post-operative
Calcium handling
Electrograms
Dominant frequency1. Background
De novo post-operative atrial ﬁbrillation (POAF) affects approxi-
mately 30–60% of patients undergoing cardiac surgery [1,2]. It is as-
sociated with increased post-operative morbidity, mortality, and
signiﬁcantly worse long-term outcomes [3–6]. The make-up or exis-
tence of any predisposing atrial substrate for POAF remains poorly
understood.
Methods to detect upstream substrate changes have proved chal-
lenging, but it is likely these changes exist in even ‘lone AF” [7]. Oneancer, Imperial College London,
South Wharf Road, London W2
siou).
land Ltd. This is an open access articlelectrical substrate feature is putative “AF nests” [8] whereby “ﬁbrillar’
myocardium is more likely to harbour sites of AF maintenance than so
called “compact” myocardium in patients with persistent AF. These
sites characteristically display a broad power spectral density (PSD) of
the sinus rhythm electrogram when analysed using Fast Fourier Trans-
form (FFT) and occur in both atria. The applicability of these ﬁndings
in earlier forms of AF such as POAF is unknown.
This study addresses the hypothesis that acute onset POAF is associ-
ated with antecedent changes in the make-up of the atrial epicardial
electrograms and calcium handling proteins that give rise to a vulnera-
ble substrate in which peri-operative triggers result in clinically signiﬁ-
cant AF. This is motivated by several lines of reasoning. Firstly, work
from our group has discovered that changes in intra-operative paced
electrogramchanges are able to identify a populationwho subsequently
go on to develop post-operative AF, related to changes in connexin ex-
pression [9]. Secondly, we also reported changes apparent in sinuse under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tors of a predisposed substratewhich the operative ‘trigger’will interact
with to produce POAF [10]. However, there is a lack of upstream atrial
structure/function studies to detect, prevent or treat POAF especially
in subjects with no antecedent AF history.
Third, in addition to these changes in connexin expression and quan-
tity, there is growing evidence to suggest that structural and electrical
remodelling occur at a transcriptional levelwhen considering themech-
anism behind abnormal atrial cardiomyocyte electrophysiology. In par-
ticular, alterations to intracellular calcium handling proteins may act as
a key component of POAF pathogenesis, as with other forms of AF [11].
Reduced SERCA2A and/or increased ryanodine receptor (RYR3) gene
expression may directly increase cytosolic Ca2+ through increased re-
uptake [12–14] and sarcoplasmic reticulum (SarcR) Ca2+ release re-
spectively [15]. Conversely, compensatory mechanisms to increase
SarcR Ca2+ re-uptake and restore Ca2+ homeostasis have also been as-
sociated with AF, including downregulation of sarcolipin (SLN), which
itself negatively regulates SERCA2A [16]. Indirectly, dysregulation of
RhoC signalling may promote AF pathogenesis through both perturba-
tion of ROCK signalling pathways, and through MAPK and PI3K
signalling which in turn may alter SarcR Ca2+ uptake [17]. Similarly,
increased expression of the pro-oxidant monoamine oxidase B may
produce intracellular Ca2+ overload through generation of H2O2, mito-
chondrial damage and increased mitochondrial Ca2+ release [18].
We set out to study this hypothesis in a group of patients with no
previous AF history, forming one of the furthest upstream atrial struc-
ture function studies carried out in the literature to date.
2. Methods
2.1. Patient selection and recruitment
This study complies with the Declaration of Helsinki, and the study was approved by
the local and regional research ethics committee (Ref: 09/H0711/23). Informed consent
was obtained from all subjects. Between November 2010 and September 2011, thirty-
four patients undergoing non-emergent, on-pump coronary artery bypass grafting
(CABG) at Imperial College Healthcare NHS Trust, were prospectively selected to partici-
pate in this study. Emergency cases, those requiring adjunctive procedures (e.g. valve
repair or replacement), patients with a prior history of any cardiac arrhythmia, thyroid
disease, those taking anti-arrhythmic agents, or undergoing surgery with mini-
cardiopulmonary bypass (CPB) systems were excluded.
All patients underwent continuous Holter (Novocor Vista 5 lead system, 2 channel re-
cording) monitoring from the time of admission to the time of surgery (12–24 h). Atrial
ﬁbrillationwas deﬁned according to Heart RhythmSociety Guidelines [19]. Post-operative
atrial ﬁbrillation (POAF) was deﬁned as new onset AF following CABG surgery in patients
with pre-operative Holter recordings demonstrating sinus rhythm and no prior history of
the arrhythmia. All episodes of AF, atrial ﬂutter, or tachycardia of at least 30 s duration
were documented. Only AF episodes N 30 s were categorised as AF positive (group
2) [19]. Patients were grouped retrospectively (following Holter analysis after discharge)
according to the absence (Group 1) or presence (Group 2) of POAF.
2.2. Electrophysiological study
The intra-operative electrophysiological protocol was designed to minimise delay in
surgery or deleterious effects to the patient should AF be induced. Immediately prior to es-
tablishing cardio-pulmonary bypass, a high-density Inquiry AFocus II catheter (Irvine Bio-
medical, St Jude Medical, Minnesota, USA) was placed by the surgeon on the lateral right
atrialwall. Stability of contactwas ensured by consistent paced capturewith high signal to
noise ratio on bipolar electrograms. Pacing was always performed at twice the pacing
threshold.
Baseline bipolar atrial electrogramswere recorded during sinus rhythm and pacing at
500ms cycle length pacing from an outer pair of electrodes. A steady-state recording of at
least 10 consecutive beats was obtained. Electrograms were digitised and stored using
BARD (Boston Scientiﬁc, USA) at standard sampling rates of 1 kHz and bandpass ﬁltered
between 30.0 Hz and 300 Hz.
Atrial ﬁbrillation (AF) was then induced by burst pacing from the same lateral elec-
trode pair to ensure consistent pacing direction and planar wavefronts. Pacing was per-
formed at 200 ms cycle length for 5 s (four bursts) and then 10 s (two bursts) until AF
occurs. AF was considered signiﬁcant if sustained for greater than 30 s [20,21].
2.3. Electrogram analysis
Intra-operativebipolar electrogramswere analysed for the following parameters in an
automated software package written in Labview based on previous studies [8,22,23]:duration, peak-to-peak amplitude, dominant frequency (DF) and activation time. Electro-
gramdurationwas calculated as time from ﬁrst deviation from baseline to return [24]. Ac-
tivation timewas deﬁned as the time from ﬁrst to last activation of the AFocus. Conduction
velocity (CV) was calculated from the manually annotated activation times using Matlab
[25]. This enabled visualisation of propagation across the AFocus II as an isochronal map
and estimated CV both using planar and circular conditions. An overall direction of prop-
agation was also calculated and maps visually assessed for atrial conduction patterns. We
present mean electrophysiological data from at least 6 consecutive beats. All electrophys-
iological analyses were conducted blinded to the patient POAF status.
2.4. Laboratory methods
2.4.1. Tissue sampling
Atrial tissue biopsieswere taken (without theuse of electrocautery) from the freewall
of the right atrium prior to cannulation and institution of cardiopulmonary bypass. This
corresponded to the site of the electrogram recordings at a consistent site at the lateral
border of the AFocus catheter. All biopsies were taken prior to pacing protocols to avoid
confounding effects of AF induction on calciumhandling proteins. Due to ethical consider-
ations of taking left atrial biopsies in patients undergoing routine coronary surgery, with
no need for left atrial access, only right atrial studies were performed.
2.4.2. RNA extraction
Whole RNA was extracted from atrial tissue using TRIZOL® Reagent as described pre-
viously [26]. RNA quality and concentrations were assessed using the Nanodrop 1000
spectrophotometer and Agilent 2100 Bioanalyser. All RNA integrity numbers (RIN) were
N7.5.
2.4.3. RT-qPCR
mRNA levels were quantiﬁed using speciﬁc TaqMan™ qPCR gene expression assays
for the following gene targets: SLN, PLN, Triadin (TRDN), SERCA2A, MYH6 (Applied
Biosystems). For each study probe an identical PCR reaction was also carried out using ri-
bosomal U6 as a control gene.
2.4.4. Reverse transcription
Reverse transcription was performed utilising a high-capacity cDNA universal RT kit
in accordancewith themanufacturer protocol (TaqMan, Applied Biosystems, Life Technol-
ogies, Paisley, UK). A total of 10 μl RT master mix was added to 5 μl of sample containing
1 μg total RNA. On completion of the RT reaction, resultant cDNAwas either used immedi-
ately or stored at−80 °C.
2.4.5. qPCR reaction
qPCR reactions were performed using TaqMan gene expression assays according to
manufacturer protocol. A total reaction volume of 10 μl was used for qPCR and an identical
control PCR reaction (U6) carried out for each sample reaction. All reactions were carried
out in three technical replicates using the Applied Biosystems 7500 fast Real-Time PCR
System [27]. Ampliﬁcation plots were examined for adequate ampliﬁcation and a delta
Rn threshold value of 0.2 (within the exponential phase of ampliﬁcation)was set to ensure
comparability across plates. Ct values were recorded for both samples and controls and
compared using the ΔΔCt method.
2.4.6. Western blotting
Protein was extracted from RA tissue samples (25–50 mg) using RIPA buffer with
added protease inhibitor cocktail (Sigma). Prior to commencing western blotting, protein
concentrations were determined by BCA assay. Proteins were separated by SDS–
polyacrylamide gel electrophoresis (10-well 10% NuPAGE® Bis-Tris Precast Gels (Life
Technologies) with MES running buffer) and blotted onto a 0.45 μm Protran®membrane.
Successful protein transferwas conﬁrmedwith Ponceau S stain.Membraneswere blocked
for 1 h at room temperature in 5% milk blocking buffer and then incubated with primary
antibody overnight at 4 °C (Rabbit polyclonal Anti-Sarcolipin (#ABT13, Millipore UK),
Mouse monoclonal Anti-Phospholamban 2D12 (#ab2865, Abcam), and Mouse monoclo-
nal Anti-SERCA2A ATPase (2A7-A1; #ab2861, Abcam). Membranes were then washed in
PBS-T (PBSwith 0.01% Tween) and incubated for 1 h in blocking buffer containing second-
ary antibody. After washing, protein bands were visualised using enhanced chemilumi-
nescence (Thermo Scientiﬁc, Rockford, IL). Quantitation of protein concentrations was
preformed using Kodak Image Station 2000M analysis software. Normalisation of protein
loading was performed against β-Actin (primary mouse β-Actin (Abcam)).
2.5. Statistical analysis
Inter-group comparisons were performed using student t-test if two groups, or one-
way ANOVA if multiple groups. Statistical signiﬁcance is reported if p b 0.05. All calcula-
tions were performed using Prism 6.0 (GraphPad, La Jolla, USA).
3. Results
34 patients undergoing non-emergent, on-pump CABG were re-
cruited. 21 did not develop POAF and were classiﬁed into Group 1, 13
patients developed POAF and were classiﬁed into Group 2. The mean
time to onset of AF was 2.5 days.
Table 2
Patient demographics: echocardiographic parameters.
Pre-operative echocardiographic parameters
n Mean ± SD p
AF Non-AF AF Non-AF
LV diastolic diameter (cm) 9 14 4.72 ± 1.06 4.59 ± 0.51 0.7305
LV systolic diameter (cm) 9 13 3.17 ± 0.94 3.17 ± 0.38 0.9964
Fractional shortening (%) 8 11 34.1 ± 10.4 33.9 ± 2.34 0.8998
IVS diastolic thickness (cm) 9 13 1.00 ± 0.18 1.05 ± 0.14 0.5756
LVPW diastolic thickness (cm) 6 12 0.90 ± 0.17 1.02 ± 0.16 0.1911
LA systolic diameter (cm) 9 12 3.83 ± 0.91 3.90 ± 3.54 0.8504
Aortic Root diameter (cm) 8 12 3.19 ± 0.32 3.18 ± 0.60 0.9528
AV peak gradient (mmHg) 9 14 9.72 ± 6.67 7.25 ± 3.26 0.3239
LVOT peak velocity (cm/s) 9 10 89.6 ± 19.4 96.2 ± 21.3 0.4847
LVOT peak gradient (mm Hg) 9 10 4.37 ± 3.56 3.84 ± 1.57 0.6898
MV E′/A′ ratio 8 14 0.83 ± 0.27 0.85 ± 0.24 0.9055
Dilated RA [% (n)] 9 13 22.2% (2) 15.4% (2) 0.683
AF– atrial ﬁbrillation; DM – diabetes mellitus; BMI – body mass index; FH – family his-
tory; CHOL – hypercholesterolaemia; HBP – hypertension; PCI – previous percutane-
ous coronary intervention; PVD – peripheral vascular disease; CVA – stroke; TIA –
transient ischaemic attack; MI – myocardial infarction.
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A summary of the pre-operative demographics is shown in Table 1.
Echocardiographic parameters were also available for the majority of
patients and are shown in Table 2. No differences were observed in
age, gender, pre-operative risk stratiﬁcation score (logEuroSCORE),
echocardiographic parameters or other recognised cardiovascular risk
factors between the two groups. Anti-arrhythmic therapy, especially
beta-blockers which may reduce POAF, was similar between groups.
3.2. Epicardial electrograms prolong and reduce in amplitude prior to onset
of AF
Atrial electrograms of induced AF showed variablemorphologywith
highly fractionated components (Fig. 1). Electrogram duration was sig-
niﬁcantly prolonged in AF (76.64 ± 29.35 ms) compared to pacing or
normal sinus rhythm (NSR) (52.89 ± 13.87 ms, p b 0.001). There was
a progressive decrease in amplitude of electrograms from NSR
(1.38 ± 0.70 mV) through pacing (500 ms 1.11 ± 0.57 mV, 200 ms
0.91 ± 0.61 mV) until AF, which had the lowest amplitude (0.85 ±
0.51 mV, p b 0.001 vs. NSR). This was associated with a prolonged acti-
vation time during rapid pacing (200 ms CL 29.41 ± 16.23 ms vs.
1000ms CL 22.64±8.40ms, p b 0.05)) suggestive of slowed conduction
[22]. However when themean wavefront propagation velocity was cal-
culated there was no signiﬁcant difference between these groups, but a
trend towards slowed CV at rapid pacing (200 ms) versus normal sinus
rhythm (78.5 ± 37.8 cm/s vs. 92.1 ± 20.6 cm/s, p = 0.07). Our method
of calculating CV showed good correlation between planar vs. circular
wavefront conditions. Activationmaps showedmostly smoothly propa-
gating simple wavefronts, consistent with early AF with minimal re-
modelling (Fig. 2) [28].Table 1
Pre-operative demographics: all patients.
%AF (n = 13) % nAF (n = 21) p-Value
Gender (M/F) 9/4 15/6 0.716
Age (yrs) 64.6 ± 11.3 59.6 ± 12.1 0.237
BMI (kg/m2) 30.2 ± 6.14 27.5 ± 3.41 0.247
Height (m) 1.62 ± 0.19 1.67 ± 0.08 0.475
Weight (kg) 80.1 ± 3.86 77.7 ± 2.69 0.623
LogEuroSCORE 0.036 ± 0.012 0.019 ± 0.0032 0.188
MI 33% 24% 0.555
Stroke 8.3% 14% 0.614
PVD 17% 4.8% 0.252
PCI 0.0% 0.0% 1.000
LMS disease 25% 33% 0.626
Hypertension 75% 76% 0.939
Hypercholesterolaemia 9.2% 90% 0.909
Family history 45% 65% 0.291
Diabetes 58% 43% 0.392
- On insulin 25% 24% 0.939
Smoking 17% 24% 0.629
Alcohol N 10 U per week 25% 25% 1.000
Pre-operative medications
Beta-blocker 64% 71% 0.652
Statin 100% 85% 0.177
Diuretic 9.0% 4.8% 0.631
ACE-inhibitors 7.3% 5.2% 0.266
Calcium channel blockers 9.0% 19% 0.461
Post-operative medications
Beta-Blocker 70% 87% 0.307
Statin 70% 93% 0.119
Diuretic 100% 100% 1.000
ACE-inhibitors 33% 50% 0.327
Digoxin 10% 0.0% 0.211
Amiodarone* 70% 6.7% 0.001
Proton pump inhibitor 90% 73% 0.307
Magnesium 70% 73% 0.856
Salbutamol (nebulised) 100% 100% 1.0003.3. Electrogram dominant frequency in sinus rhythm is higher than AF
Fourier analysis of the electrogram showed a highermean dominant
frequency in sinus rhythm than in AF (89.3 ± 4.9 Hz vs. 75.9 ± 1.8 Hz
respectively, p = 0.006). The pacing rate affected the magnitude of
this result, with the largest spectral differences occurring between AF
vs. NSR and 1000 ms pacing. A summary of all electrogram ﬁndings is
shown in Fig. 3. An example of AF and sinus rhythm electrograms
with corresponding power spectral density plots of the electrogram is
shown in Fig. 4. Patients able to be paced intra-operatively into AF had
higher DF at the site of AF initiations during sinus rhythm than those
who did not (96.2 ± 6.2 Hz vs. 74.9 ± 5.6 Hz, p = 0.04) (Fig. 5).
3.4. Gene and protein expression of intracellular calcium handling proteins
POAF was found to be associated with a signiﬁcant reduction in the
expression of SLNmRNA (p=0.0080) aswell as a less signiﬁcant reduc-
tion inMYH6 (p=0.0297) and SERCA2A (p=0.0343) gene expression.
No signiﬁcant difference was observed in PLN (p = 0.7963) or Triadin
(p = 0.7963) gene expression (Fig. 6).
Sarcolipin (SLN) protein levelswere evaluated in the atrial tissue of a
subgroup of 4 POAF and 7 non-POAF patients. Patients developing POAF
had a signiﬁcantly lower level of SLN protein expression in atrial tissue
samples taken at the time of surgery when compared to non-POAF pa-
tients (p = 0.0242) (Fig. 7a).
No signiﬁcant difference was seen in the expression of the regula-
tor protein phospholamban (PLN) (monomer p = 0.6095; pentamer
p = 0.8952) or in the overall expression of SERCA2a (p = 0.6571)
(Fig. 7b–d). Insufﬁcient atrial tissue sample was available to allow
for evaluation of atrial myosin heavy chain 6 (cardiac muscle, alpha
isoform) protein expression in the current study.
4. Discussion
This study is the ﬁrst to identify that intraoperative electrograms ob-
tained during sinus rhythm in patientswith noprior history of AF have a
higher dominant frequency (DF) than those obtained during AF. Fur-
thermore, patients in whom AF was inducible demonstrated higher SR
DF electrograms than those in whom AFwas non-inducible. These elec-
trical changes were coupled with altered cardiomyocyte calcium han-
dling apparent in POAF atria prior to the onset of arrhythmia, as
evidenced by changes in SLN, MYH6 and SERCA2a gene expression
and reduced sarcolipin protein expression.
Fig. 1. Induced AF shows rapidly changing complex electrogrammorphology in 72-year-old man with no history of AF. A) Episode of induced intra-operative AF immediately after atrial
pacing at 200ms CL from bipole 5/6. First beat of induced AF annotated in red, showing sequential propagation across catheter bipoles. S demarcates pacing stimulation artefact. B) Select
bipoles after 30 s of sustained AF showmarked electrogram complexity. Black bars indicate 1000 ms in both panels.
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Despite no prior history of any cardiac arrhythmia in our patients,
therewas a signiﬁcant increase in theDF of the sinus rhythmelectrogramFig. 2. Activation maps of acutely induced human AF show coherent wave propagation. A) A
Matlab schematic with colour coding and overall activation vector labelled (blue arrow). C)
with calculated CV at top. D) 4 cycles of AF showing relatively consistent activation patterns uwhen compared to the electrogram in AF. Whilst this is compatible with
the ‘AF nest’ theory, whereby sources in the atrium harbouring AF are de-
tectable at baseline in patients undergoing AF ablation, these ﬁndings are
the ﬁrst in such an upstream, unremodelled cohort [8]. In that study,Focus II with labelled electrodes 1 and 6. B) Manually assigned activation times on spiral
Isochronal map from activation times showing smooth propagation across AFocus area
sing above steps.
Fig. 3. Summary of intra-operative electrogram ﬁndings when analysed by pacing rate or normal sinus rhythm (NSR). For further details please refer to text.
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no prior history of AF), with AF only inducible in this patient. This has par-
allels to the ﬁndings we present here, whereby patients inducible into AF
had higher electrogram DF in sinus rhythm than those who were not.Fig. 4. Examples of AF and sinus electrograms from a 73-year-old man with induced intra-ope
Fourier Transform (FFT) spectral analysis show dominant frequency peak at 70 Hz. B) Same
fractionation is seen in top two channels. Overall FFT showed a frequency peak at 90 Hz. BlackVariations in connexin expression and complexity of wavefront
propagation have previously been shown to indicate those at risk of
post-operative AF [9,10]. However, these changes weremainly observed
in during paced rhythms. Our ﬁndings are the furthest ‘upstream’rative AF. A) 3 bipoles from AFocus II after sustained AF for 30 s with corresponding Fast
bipoles during sinus rhythm in the same patient prior to AF induction. High frequency
bar represents 1000 ms in both electrogram panels. Mean data is shown in Fig. 3.
Fig. 5. Dominant frequency (DF) of normal sinus rhythm (NSR) electrograms at the site of
AF initiations is higher in patients who sustain AF (NSR AF) intra-operatively (*p b 0.05).
585J.A.B. Zaman et al. / International Journal of Cardiology 220 (2016) 580–588electrogram changes detected so far in human AF. We have shown that
patients with no clinical history of AF possess the substrate to maintain
AF, and that this may be identiﬁable by high DF on spectral analysis of
intra-operative electrograms.
Our site of recording in the lateral RA was consistent with previous
work showing that lateral RA AF nests can occur [8,29]. This would
avoid potential interactions with ganglionated plexi as there are no dis-
crete ganglia in that area [30]. The mechanisms for the AF nest in this
site deserve further prospective study, but may involve the crista
terminalis or the presence of thick-thin ﬁbre transitions, which may
act as AF anchors in the left atrium [31]. Notably in the original descrip-
tion of AF nests, 47% of patients had these at the lateral RAwall near the
crista terminalis. Furthermore, differences between electrogram mor-
phology from endo-epicardial recordings have been shown in patients
with no history of prior AF [32].
4.2. Conduction time prolongs with rapid pacing prior to AF initiation
Rapid pacing to induce AF causes prolongation of conduction
time, which correlates with conduction slowing [22]. Although
both planar and circular wavefront conditions assumedmay be over-
ly simplistic, there was good agreement between both methods. Fur-
thermore, similar assumptions have limited previous in vivo atrial
CV measurements, especially during AF. By showing both conditions
give similar results, we demonstrate the validity of the CV calcula-
tions and further conﬁrm that the episodes of acutely induced peri-
operative AF were not due to intrinsic pre-existing conduction de-
fects. In this study we nonetheless observed prolonged activation
time with coherent propagation, demonstrated by broad smooth
wavefronts on activation maps.
When considering the potential underlying cellularmechanisms be-
hind electrogram fractionation and high dominant frequencies in POAF
patients, potential structural mechanisms for AF nests include reduced
connexin expression, underlying autonomic ganglia [30], localised
microﬁbrosis [33] and functional causes of fractionation [34]. Functional
causes would not be present during sinus rhythm, but are important in
AF initiation as conduction slows. We have recently demonstrated this
cause of electrogram fractionation in a goat model of tachy-paced AF
secondary to altered gap junction remodelling [35]. Signiﬁcantly, inaddition to the above documented electrical substrate factors, we
found perturbed calcium handling in POAF pathogenesis.
4.3. Electrical remodelling: dysregulation of cardiomyocyte calcium
handling in POAF atria
It is known that intracellular calcium overload can lead to action
potential alternans and summated extracellular potentials (or
after-depolarisations) [36], which may lead to altered electrogram
composition. Furthermore, rapid pacing can itself lead to cellular calci-
um overload, thereby forming an important arrhythmic focus. The
atria of POAF patients demonstrated a signiﬁcant reduction in sarcolipin
(SLN) gene and protein expression when compared to the atria of pa-
tients maintaining sinus rhythm. Sarcolipin is a small 4 kDa, 31 amino
acid protein (encoded by the SLN gene, location 11q22), expressed pre-
dominantly in atria, that acts to inhibit the sarcoplasmic reticulum
ATPase (SERCA) independent to its primary regulatory protein phos-
pholamban (PLN). This correlates with ﬁndings in patients with chronic
AF as evidenced by Shanmugamet al. who observed a similar signiﬁcant
decrease in sarcolipin protein expression [16,37]. Furthermore, our re-
sults also corroborate previous ﬁndings that this mechanism of SERCA
regulation in AF occurs independent to the activity of the regulatory
protein phospholamban, the expression of which remains unchanged
[16].
Through inhibition of SERCA activity, SLN acts to reduce cellular re-
uptake of Ca2+ into the sarcoplasmic reticulum (SarcR). Knockout of
SLN removes this inhibition of SERCA2a in cardiac muscle, enhances
SarcR Ca2+ reuptake and promotes SarcR Ca2+ overload [36,38]. This
in turn shortens the effective refractory period and thus may increase
susceptibility to AF. Furthermore, increased SarcR calcium load may
also lead to diastolic calcium leak giving rise to the potential for delayed
after depolarisations and thus triggeredAF [39]. Beyond this, SLNknock-
outmice also display increased cardiomyocyte L-type Ca2+channel ac-
tivity hence greater Ca2+ inﬂux in response to an action potential.
The observed reduction in SLN expression in our POAF patient co-
hort may therefore represent an adaptive mechanism to counter in-
creased intracellular calcium and preserve SarcR calcium stores
through removal of inhibition of SERCA2a. Furthermore, it is possible
that the accompanying reduction in MYH6 gene expression repre-
sents an MHC isoform switch to reduce α-MHC and increase β-MHC
representing a hallmark of cellular reversion to a foetal phenotype
[40]. Indeed, β-MHC isoforms are less sensitive to intracellular calcium,
and require an approximately 50% higher intracellular free calcium con-
centration to achieve half-maximal tension thanα-MHC [41]. Therefore
an MHC class switch may dampen the contractile response to intracel-
lular calcium overload and ultimately prevent contractile failure in re-
sponse to chronic calcium overload and metabolic stress [40].
Together these changes suggest that POAF may be associated with a
basal state of cellular calcium overload prior to the onset of the arrhyth-
mia. Although the exact mechanism for this remains unclear, a number
of factors previously associated with AF pathogenesis may be responsi-
ble for this increase in intracellular Ca2+ including increased oxidative
stress, mitochondrial dysfunction and increased cellular glucose con-
centration [42]. As such, these stimuli may in fact represent the under-
lying causative mechanism behind the atrial remodelling observed in
this POAF patient cohort.
4.4. Limitations
It is important to consider a number of limitationswhen interpreting
these results. Firstly, the study number remains small and further vali-
dation is required in a larger patient cohort. This limited correlation of
gene expression with arrhythmia phenotype, although such studies
are currently underway. The electrophysiological ﬁndings need veriﬁca-
tion with greater number of sites in the right atrium and importantly
the left atrium, which is predominantly responsible for human AF. We
Fig. 6. RT-qPCR results showing signiﬁcantly lower (a) sarcolipin (SLN) (p= 0.0080); (b) SERCA2A (p= 0.0343), and (c) MYH6 (p= 0.0297) gene expression in the right atrial tissue of
POAF compared to non-POAF. No signiﬁcant difference was observed in (d) phospholamban (PLN) (p = 0.7963), or (e) triadin (TRDN) (p = 0.7963) gene expression.
586 J.A.B. Zaman et al. / International Journal of Cardiology 220 (2016) 580–588chose not to perform LA pacing as the lack of structure function data
would have not addressed our primary hypothesis and is under investi-
gation in a separate IRB protocol enrollingmitral valve surgical patients
at our centre. Furthermore, POAF represents a speciﬁc phenotype of AF
in which the LA contribution remains poorly characterised, and we
chose patients with no antecedent history or AF and normal LA diame-
ter to exclude undetected atrial substrate. Also, unipolar electrogramswere recorded but not analysed due to poor signal:noise ratio. These
will not have the direction dependence and electrode orientation effects
that bipolar electrodes are subject to. We minimised these factors by
using a circular array with electrode pairs in all directions of wavefront
propagation.
Furthermore, as this study was not originally designed to examine
cellular calcium regulation, although no difference was observed in
Fig. 7.Western blot demonstrating: (a) signiﬁcantly lower sarcolipin (SLN) (p= 0.0242), and unchanged (b) monomeric phospholamban (p= 0.6095), (c) pentameric phospholamban
(p= 0.8952), and (d) SERCA2A (p = 0.6751) protein expression in the right atrial tissue of patients developing post-operative atrial ﬁbrillation (POAF) compared to those maintaining
sinus rhythm. Boxes denote samples from POAF patients.
587J.A.B. Zaman et al. / International Journal of Cardiology 220 (2016) 580–588the expression of the SERCA regulator PLN, these results represent only
absolute PLN expression and the phosphorylation state of PLN was not
investigated. Phosphorylation of PLN acts to inhibit its binding with
SERCA thus removing its inhibitory effect and promoting Ca2+ reuptake
into the sarcoplasmic reticulum. As a result, in order to isolate the effect
of SLN down-regulation on calcium transport, future work must ensure
both PLN and phosphorylated-PLN levels are independently deter-
mined. Similarly, a restriction in sample availability did not allow for
quantiﬁcation of myosin heavy chain protein expression and therefore
relative changes in MYH6 (and likewise MYH7) expression must now
be validated at the protein level [43]. Third, it is important to consider
other regulatory mechanisms that may modulate intracellular calcium
such as adrenergic stimulation of protein kinase A (PKA) which may
not only lead to phosphorylation of phospholamban but also of L-type
calcium channels, which in turn increase calcium cycling andspeeding up SarcR calcium release [44]. Similarly PKA phosphoryla-
tion of Troponin I may also act to lower myoﬁlament sensitivity to
Ca2+ thus reducing the contractile response to intracellular calcium
load [45].
5. Conclusions
Post-operative atrial ﬁbrillation is associated with structural and
electrical remodelling present prior to exposure to surgical stress as ev-
idenced by altered paced epicardial electrogram morphology and high
frequency spectral components during sinus rhythm, accompanied by
changes in the expression of calcium handling proteins. These novel
peri-operative upstream substrate changes suggest a cellular mecha-
nism predisposing to post-operative AF, manifest in the electrogram
prior to the onset of AF. Further work must now focus on validating
588 J.A.B. Zaman et al. / International Journal of Cardiology 220 (2016) 580–588these ﬁndings in a larger patient cohort, in order to both improve surgi-
cal risk prediction and develop the next generation of preventative
therapies.
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